Searchable abstracts of presentations at key conferences in endocrinology

ea0022p724 | Signal transduction | ECE2010

Spatial and temporal regulations of MAPKinases ERK1/2 in the somatolactotroph cell line GH4C1

Zeiller Caroline , Blanchard Marie-Pierre , Pertuit Morgane , Thirion Sylvie , Enjalbert Alain , Barlier Anne , Gerard Corinne

Somatotroph adenomas are characterized by growth hormone hypersecretion and cell proliferation. We have previously identified crosstalk between the cAMP pathway and the MAPKinases ERK1/2 cascade and shown the central place of the MAPKinases in the control of the pituitary function in GH4C1 somatolactotroph cell line.The spatio-temporal organization of the signalling partners governs signalling fidelity and encodes the specificity of biological responses....

ea0063gp199 | Adrenal and Neuroendocrine - Clinical | ECE2019

LC-MS/MS measurement for urinary aldosterone improves primary aldosteronism screening

Travers Simon , Blanchard Anne , Cornu Erica , Faucard Catherine , Baffalie Laurence , Azizi Michel , Houillier Pascal , Amar Laurence , BARON Stephanie

Objective: Primary aldosteronism (PA) is the first cause of endocrine hypertension accounting for about 6% of all cases of hypertension. According to international guidelines, PA screening is based on plasma aldosterone-to-renin concentration ratio (ARR) computation. Nevertheless, measurement of urine aldosterone excretion may be of interest since it integrates aldosterone secretion over 24 hours. However, available urine aldosterone immuno-assays have poor specificity.<p ...

ea0032oc1.2 | Pituitary &amp; Molecular Endocrinology | ECE2013

Involvement of the constitutive activity of the GHS-R1a (ghrelin G-protein coupled receptor) in the tumorigenesis of somatotroph adenomas

Mear Yves Louis , Donato Xavier Come , Blanchard Marie Pierre , Defilles Celine , Lisbonis Christophe , Barlier Anne , Enjalbert Alain , Thirion Sylvie

Pituitary tumors are most usual intracranial tumors, displaying hormonal hyper-secretion with in some cases a sustained cell proliferation. The somatotroph adenomas are characterised by a GH hypersecretion. The current treatments are based on somatostatinergic or dopaminergic agonists. Unfortunately, there is steel 50% of patients, which remain insensitive to these treatments. The aim of our work is to find a pharmacological alternative to treat the patients resistant to the c...

ea0029oc10.3 | Pituitary Clinical 2 | ICEECE2012

Pathophysiology of renal calcium handling in acromegaly revisited

Kamenicky P. , Blanchard A. , Gauci C. , Salenave S. , Letierce A. , Lombes M. , Azizi M. , Prie D. , Souberbielle J. , Chanson P.

Background: Hypercalciuria is frequent in patients with acromegaly, but it is unclear how GH/insulin-like growth factor 1 (IGF1) regulate renal calcium handling. Elevated fasting plasma calcium levels despite increased glomerular filtration suggest enhanced renal calcium reabsorption.Objective: To investigate the impact of acromegaly on phosphocalcium metabolism.Design: Prospective sequential study (ClinicalTrials.gov Identifier: N...

ea0063gp17 | Calcium and Bone 1 | ECE2019

Utility of a second technecium99mMIBI-SPECT imaging before re-operating in patients with persistent sporadic primary hyperparathyroidism: results of a retrospective multicentric study

Frey Samuel , Couette Clement , Tresallet Christophe , Hamy Antoine , Caillard Cecile , Blanchard Claire , Lhermite Emilie , Menegaux Fabrice , Drui Delphine , Ansquer Catherine , Mirallie Eric

Introduction: Persistent primary hyperparathyroidism (pHPT) occurs in 2.5 to 15% of cases after parathyroidectomy. Pre-operative localization studies (usually 99mTc-MIBI and cervical ultrasonography (US)) allow focused surgical approach (unilateral neck exploration or minimally invasive parathyroidectomy). Few studies have evaluated the best pre-reoperative approaches in case of persistent sporadic pHPT. The aim of our study is to evaluate the value of a second pre-...

ea0063p492 | Calcium and Bone 2 | ECE2019

Hyperparathyroidism in patients with X-linked hypophosphatemia

Lecoq Anne-Lise , Chaumet-Riffaud Philippe , Blanchard Anne , Rothenbuhler Anya , Lambert Benoit , Bay Alexandrine , Silve Caroline , Piketty Marie , Chanson Philippe , Brailly-Tabard Sylvie , Linglart Agnes , Kamenicky Peter

Background: X-linked hypophosphatemia (XLH) is a rachitic disorder characterized by renal tubular phosphate wasting resulting from increased circulating activity of the fibroblast growth factor FGF23. Secondary and tertiary hyperparathyroidism have been reported in XLH patients in small retrospective studies, however this complication has never been systematically evaluated in a large cohort.Aim of the study: To compare parathyroid function of adult XLH ...

ea0029oc9.6 | Endocrine Tumours &amp; Translation | ICEECE2012

First in vitro study of human gastroenteropancreatic-neuroendocrine tumors: comparative effect of octreotide and pasireotide

Mohamed A. , Blanchard M. , Albertelli M. , Niccoli P. , Monges G. , Garcia S. , Moutardier V. , Delpero J. , Enjalbert A. , Florio T. , Ferone D. , Saveanu A. , Barlier A.

Somatostatin analogs (SSAs) such as octreotide (OCT) are currently effective in controlling most hypersecretion associated symptoms of Gastoenteropancreatic-neuroendocrinetumors (GEP-NETs). The results of the phase IIIb PROMID trial showed that OCT doubled time to progression for patients with metastatic neuroendocrine midgut tumors compared with placebo. SSAs act on different intracellular pathways through different somatostatin receptor (Sst) subtypes. While OCT is mainly an...

ea0063p374 | Thyroid 1 | ECE2019

Impact of total thyroidectomy on quality of life: the prospective ThyrQoL multicenter trial

Borel Frederic , Mirallie Eric , Tresallet Christophe , Hamy Antoine , Mathonnet Muriel , Lifante Jean-Christophe , Brunaud Laurent , Marret Olivier , Caillard Cecile , Espitalier Florent , Menegaux Fabrice , Drui Delphine , Hardouin Jean-Benoit , Blanchard Claire

Introduction: Health-related Quality of Life (HR-QoL) is usually impaired in patients with thyroid diseases compared to the general population. Thyroidectomy is largely performed in case of benign thyroid disease, and can be associated with severe long-term complications: vocal cord palsy (VCP), hypoparathyroidism. Our goal was to report the long-term HR-QoL outcomes after thyroidectomy using the MOS 36-item short form health survey (SF-36) self-questionnaire.<p class="abs...

ea0063p465 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Measurement of metanephrine in adrenal venous sampling may help subtyping primary aldosteronism

Baron Stephanie , Bailly Clement , Cornu Erica , Blanchard Anne , Bergerot Damien , Pagny Jean-Yves , Laffy Pierre-Yves , Carrere Thierry , Grataloup Christine , Zinzindohoue Franck , Reznik Yves , Azizi Michel , Billaud Eliane , Amar Laurence

Objective: Adrenal venous sampling (AVS) is the gold standard method to assess lateralization of aldosterone secretion in patients with primary aldosteronism (PA). The selectivity index (SIcortisol, the adrenal to peripheral vein ratio of cortisol concentrations) determines correct catheter positioning during AVS. The lateralization index (LIcortisol, the aldosterone to cortisol ratios between adrenal veins) distinguishes unilateral aldosterone producing ...

ea0049gp19 | Adrenal 2 | ECE2017

Plasma cortisol and aldosterone responses to insulin tolerance test and sodium depletion in women with non classic 21-hydroxylase deficiency caused by bi-allelic CYP21A2 mutations (NC-CAH)

Kamenicky Peter , Blanchard Anne , Lamaziere Antonin , Donadille Bruno , Duranteau Lise , Salenave Sylvie , Pietri Laurence , Raffin-Sanson Marie Laure , Gautier Jean-Francois , Chanson Philippe , Maitre Sophie Christin , Tardy Veronique , Bouc Yves Le , Brailly-Tabard Sylvie , Young Jacques

NC-CAH is diagnosed in pubertal/post-pubertal women because of androgen excess however, the risk of potential adrenal insufficiency is not known, and indication of systematic glucocorticoid replacement therapy is controversial.Design: Prospective controlled clinical study in a tertiary referral center. 20 women with NC-CAH (serum stimulated 17-OHP >10 ng/ml/250 μg, Synacthen) comparatively to matched healthy women, were included if they had not ...